Skip to main content

Cerebral Venous Thrombosis

  • Protocol
  • First Online:
Cerebrovascular Disorders

Part of the book series: Neuromethods ((NM,volume 170))

Abstract

Cerebral venous thrombosis (CVT) is a relatively uncommon but serious neurologic disorder that is potentially reversible with prompt diagnosis and appropriate medical care. The clinical presentation is extremely variable and nonspecific, and imaging is critical in diagnosis. Many risk factors for CVT have been reported, most of which overlap with those of peripheral venous thromboembolism. Patients can be diagnosed with magnetic resonance imaging, CT venography, or catheter angiography. The management of CVT patients includes treatment of associated conditions, anticoagulation with parenteral heparin, prevention of recurrent seizures, and surgical decompression in patients with large venous infarcts/hemorrhages with impending herniation. After the acute phase, patients should be anticoagulated for up to 3–12 months based on etiology. In patients who develop clinical and radiological signs of impending herniation, decompressive surgery can be both lifesaving and result in a good functional outcome. The prognosis is otherwise favorable in most cases, especially compared to arterial stroke, although a significant proportion of patients do suffer from chronic symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Gokhale S, Lahoti SA (2014) Therapeutic advances in understanding pathophysiology and treatment of cerebral venous sinus thrombosis. Am J Ther 21(2):137–139

    Article  Google Scholar 

  2. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F (2004) Prognosis of cerebral vein and dural sinus thrombosis: results of the international study on cerebral vein and dural sinus thrombosis (ISCVT). Stroke 35:664–670

    Article  Google Scholar 

  3. Filippidis A, Kapsalaki E, Patramani G, Fountas KN (2009) Cerebral venous sinus thrombosis: review of the demographics, pathophysiology, current diagnosis, and treatment. Neurosurg Focus 27(5):E3

    Article  Google Scholar 

  4. Yoshikawa T, Abe O, Tsuchiya K, Okubo T, Tobe K, Masumoto T et al (2002) Diffusion-weighted magnetic resonance imaging of dural sinus thrombosis. Neuroradiology 44:481–488

    Article  CAS  Google Scholar 

  5. Saposnik G, Barinagarrementeria F, Brown RD Jr et al (2011) American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:1158–1192

    Article  Google Scholar 

  6. de Bruijn SFTM (2001) Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 70(1):105–108

    Article  Google Scholar 

  7. Dentali F (2006) Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 107(7):2766–2773

    Article  CAS  Google Scholar 

  8. Bousser M-G, Crassard I (2012) Cerebral venous thrombosis, pregnancy and oral contraceptives. Thromb Res 130:S19–S22

    Article  Google Scholar 

  9. Tchaikovski SN, Rosing J (2010) Mechanisms of estrogen induced venous thromboembolism. Thromb Res 126:5–11

    Article  CAS  Google Scholar 

  10. Wysokinska EM, Wysokinski WE, Brown RD et al (2008) Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 70:627–633

    Article  CAS  Google Scholar 

  11. Coutinho J et al (2013) Cerebral venous thrombosis and thrombophilia: a systematic review and meta-analysis. Semin Thromb Hemost 39(8):913–927

    Article  Google Scholar 

  12. Raper DMS et al (2016) Geographically remote cerebral venous sinus thrombosis in patients with intracranial tumors. World Neurosurg 98:555–562

    Article  Google Scholar 

  13. Azin H, Ashjazadeh N (2008) Cerebral venous sinus thrombosis—clinical features, predisposing and prognostic factors. Acta Neurol Taiwan 17(2):82–87

    PubMed  Google Scholar 

  14. Sparaco M, Feleppa M, Bigal ME (2015) Cerebral venous thrombosis and headache – a case-series. Headache 55(6):806–814

    Article  Google Scholar 

  15. Ebright JR, Pace MT, Niazi AF (2001) Septic thrombosis of the cavernous sinuses. Arch Intern Med 161(22):2671–2676

    Article  CAS  Google Scholar 

  16. Khatri IA, Wasay M (2016) Septic cerebral venous sinus thrombosis. J Neurol Sci 362:221–227

    Article  Google Scholar 

  17. Bousser M-G, Ferro JM (2007) Cerebral venous thrombosis: an update. Lancet Neurol 6(2):162–170

    Article  CAS  Google Scholar 

  18. Kumral E, Polat F, Uzunköprü C, Çallı C, Kitiş Ö (2011) The clinical spectrum of intracerebral hematoma, hemorrhagic infarct, non-hemorrhagic infarct, and non-lesional venous stroke in patients with cerebral sinus-venous thrombosis. Eur J Neurol 19(4):537–543. https://doi.org/10.1111/j.1468-1331.2011.03562

    Article  PubMed  Google Scholar 

  19. Simon S, Yao T, Ulm AJ, Rosenbaum BP, Mericle RA (2009) Dural arteriovenous fistulas masquerading as dural sinus thrombosis. J Neurosurg 110(3):514–517

    Article  Google Scholar 

  20. Crassard I, Soria C, Tzourio C et al (2005) A negative D-dimer assay does not rule out cerebral venous thrombosis: a series of 73 patients. Stroke 36:1716–1719

    Article  Google Scholar 

  21. Einhaupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, Stam J (2006) EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 13(6):553–559

    Article  CAS  Google Scholar 

  22. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, Haberl RL, Pfister HW, Schmiedek P (1991) Heparin treatment in sinus venous thrombosis [published correction appears in Lancet. 1991; 338:958]. Lancet 338:597–600

    Article  CAS  Google Scholar 

  23. Misra UK, Kalita J, Chandra S, Kumar B et al (2012) Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: a randomized controlled trial. Eur J Neurol 19:1030–1036

    Article  CAS  Google Scholar 

  24. Canhao P, Cortesao A, Cabral M, Ferro JM, Stam J, Bousser MG, Barinagarrementeria F, ISCVT Investigators (2008) Are steroids useful to treat cerebral venous thrombosis? Stroke 39:105–110

    Article  CAS  Google Scholar 

  25. Canhao P, Ferro JM, Lindgren AG et al (2005) Causes and predictors of death in cerebral venous thrombosis. Stroke 36:1720–1725

    Article  Google Scholar 

  26. Ferro JM, Canhao P, Bousser MG, Stam J, Barinagarrementeria F, ISCVT Investigators (2008) Early seizures in cerebral vein and dural sinus thrombosis: risk factors and role of antiepileptics. Stroke 39:1152–1158

    Article  Google Scholar 

  27. Van der Hulle T, Kooiman J, den Exter PL et al (2014) Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Hemost 12(3):320–328

    Article  Google Scholar 

  28. Shulman S, Kearon C, Kakkar AK et al (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361:2342–2352

    Article  Google Scholar 

  29. Geisbüsh C, Richter D, Herweh C, Ringleb PA, Nagel S (2014) Novel factor Xa inhibitor for the treatment of cerebral venous and sinus thrombosis – first experience in 7 patients. Stroke 45:2469–2471

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sameen Jafari .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Jafari, S., Albin, C., Izzy, S. (2021). Cerebral Venous Thrombosis. In: Al-Mufti, MD, F., Amuluru MD, K. (eds) Cerebrovascular Disorders. Neuromethods, vol 170. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1530-0_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1530-0_22

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1529-4

  • Online ISBN: 978-1-0716-1530-0

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics